Sutro Biopharma Inc
NASDAQ:STRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sutro Biopharma Inc
NASDAQ:STRO
|
US |
|
P
|
Pembina Pipeline Corp
F:P5P
|
CA |
|
R
|
Richter Gedeon Vegyeszeti Gyar Nyrt
XMUN:RIG2
|
HU |
|
Rexel SA
PAR:RXL
|
FR |
|
A
|
Atlantic Sapphire ASA
XMUN:4AS
|
NO |
|
M
|
MFC Asset Management PCL
SET:MFC
|
TH |
|
Evaxion Biotech A/S
NASDAQ:EVAX
|
DK |
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
IL |
|
S
|
Saul Centers Inc
F:SA4
|
US |
|
C
|
Corpfin Capital Prime Retail II Socimi SA
F:F95
|
ES |
|
P
|
Peugeot Invest SA
XMUN:FFP
|
FR |
|
Peugeot Invest SA
OTC:SFFFF
|
FR |
|
A
|
Ameren Corp
F:AE4
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKD
|
JP |
|
A
|
Archrock Inc
F:54E
|
US |
|
Enact Holdings Inc
NASDAQ:ACT
|
US |
|
Atlantic Sapphire ASA
OSE:ASA
|
NO |
|
C
|
City Developments Ltd
OTC:CDEVF
|
SG |
|
S
|
Sonic Automotive Inc
F:SA8A
|
US |
|
H
|
Helix Energy Solutions Group Inc
XMUN:CTV
|
US |
|
T
|
Terracom Ltd
OTC:TERCF
|
AU |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
Bankruptcy Probability
Sutro Biopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sutro Biopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Sutro Biopharma Inc
NASDAQ:STRO
|
411.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
454.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
209.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sutro Biopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sutro Biopharma Inc has no debt.
You can find a full breakdown on its Balance Sheet.
